Southern PA

SOCRA Southern Pennsylvania Chapter Meeting

Wednesday, April 6, 2022
3:00-4:00PM EST

Location: Zoom Remote Meeting
You must register in advance to receive log-in information and attendance certificate:
Please click on the link below to register. For any issues with registration, contact Jessica Rowe at jrowe4@wellspan.org

Register Here!


After registering, you will receive a confirmation email containing information about joining the meeting.

The Clinical Significance of Assessing Abnormalities: To AE, SAE or Neither?

Presenter: : Jeannie Farnsworth, MS, BS, CCRP, MRQA
Clinical Scientist for Vertex Pharmaceuticals on behalf of ICON
Phoenix Senior Chapter Chair; National SOCRA Board of Directors
Instructor and Consultant, Clinical Research Fastrack

Jeannie has over 21 years of experience in roles such as clinical research coordinator, manager, contractor, consultant, trainer, monitor and is now functioning as a Clinical Scientist. With experience in working on both drug and device clinical trials, she has predominant experience in study startup, protocol procurement, trial operations, quality management, staff training, and is currently focused on safety analyses.

Learning Objectives:
By the end of this seminar, attendees will have an increased knowledge of:

  1. To better understand assessment abnormalities against the subject’s overall health and impact on study involvement
  2. To gain better clarity on “clinically significant” vs. “not clinically significant”
  3. To appreciate how and when abnormalities should be considered AEs or SAEs

Credits Available:  1 CE credit for SoCRA members

Any questions? Email jrowe4@wellspan.org

 

 


 

Chapter Co-Chairs:

Jessica Rowe
Email

Kirsten Shuler
Email